Kirkland Advises Knox Lane on Strategic Investment in Spectrum Science

Kirkland & Ellis advised Knox Lane, a growth-oriented investment firm that is focused on partnering with businesses in the services and consumer sectors, on its strategic investment in Spectrum Science (Spectrum), an independent, integrated marketing, communications and media firm focused on the pharmaceutical, biotech and broader life science industries. The partnership will support the continued expansion of Spectrum’s strategic communications capabilities, while also enabling it to build on its unique approach to clinical trial recruitment, broaden consultative capabilities for medical affairs clients and drive enhanced tech enablement throughout the organization.

Read Knox Lane’s press release

The Kirkland team was led by corporate partners Evan Roberts and Hamed Meshki; debt finance partners Katie Taylor and Dave Nemecek; tax partner Anne Kim; and investment funds partners Justin Solomon and Michael Lee.